SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ted Moeller who wrote (110)2/22/1997 1:42:00 PM
From: Zeev Hed   of 371
 
Ted: I think that IMMU had too many financing overseas, and some of this was convertible debt which is coming on the market everytime the stock hits 7. I got out there myself, after not having bailed out at 13 and after buying at 7, so having in essence dead money for almost a year. I still believe it is a great technology, but with 40 MM shares (or thereabout) outstanding and another two years before we see the therapeutic products (which in my opinion are the real big money makers) being approved for any use and more years before full deployment. So, I think that I have ample opportunutiy to pick the stock back under 5.

Zeev
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News